Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis.
Enrico HefflerFabiana SaccheriMarta BartezaghiGiorgio Walter CanonicaPublished in: Clinical and translational allergy (2020)
In an observational real-world setting, add-on omalizumab for severe allergic asthma was effective in improving asthma control, lung function and in reducing exacerbations, including in those patients with CRSwNP.